Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientific hunch poised to save thousands from toxic fish poisoning

22.10.2008
A neuroscientist at UQ's Queensland Brain Institute has found a way to combat a debilitating illness that affects an estimated 50,000 people a year in tropical regions.

Ciguatera poisoning – which often results in acute nausea, vomiting and painful gastrointestinal episodes – is caused by eating fish that have fed on a micro algae that are toxic to mammals and often associated with large algal blooms known as red tides.

Cases of ciguatera poisoning have been documented for more than 200 years – and were recorded and described by Captain Cook on his second voyage to the Pacific in 1774.

Recently, scientists have discovered that the patented compound brevenal could be used to make an effective treatment for neurotoxic shellfish poisoning (NSP), a condition related to ciguatera poisoning.

Acting initially on a hunch, QBI neuroscientist Associate Professor Fred Meunier hypothesised that brevenal could be adapted to combat ciguatera poisoning.

Simultaneously, and unbeknown to Dr Meunier, Dr Dan Baden at the University of North Carolina Wilmington (USA) was also considering adapting brevenal to fight ciguatera.

The two scientists soon became aware of each other's interest and began discussing the possibility that the compound active against NSP could have the same therapeutic effect on ciguatera toxins.

Along with Dr Dan Baden, Dr Jordi Molgo (National Center For Scientific Research, France) and Dr Richard Lewis at UQ's Institute for Molecular Bioscience, Dr Meunier pressed on to obtain a small batch of both ciguatera toxin and brevenal to test their hypothesis.

"It now seems that we have found a way of blocking the effect of the ciguatera toxin on sodium channels without affecting their function of propagating the electrical signals in neurons," Dr Meunier said.

One of the main problems with ciguatera is that there are few, if any, effective treatments for the acute impact it has on the health of humans and marine mammals.

"There is one drug available for ciguatera sufferers but a randomised trial conducted by another research group in 2002 found it to be no better than a placebo," Dr Meunier said.

Armed with the knowledge of how the ciguatera toxin affects the body, Dr Meunier and his research collaborators are now looking to develop a drug that will short-circuit the ciguatera toxin's effect in mammals. The process of synthesising and safely delivering the drug for human patients will require extensive trials.

QBI Communications | EurekAlert!
Further information:
http://www.uq.edu.au

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>